Ales Marek is a highly experienced professional in the field of organic chemistry and radiochemistry. Currently serving as the Head of the Radioisotope Facility at IOCB Prague since January 2010, Ales is responsible for the custom synthesis of radioactive molecular tracers, radiometric services, and radiation safety supervision. Ales has a strong background in synthetic radiochemistry, having worked on the synthesis of radiolabeled compounds and collaborations in providing radio-labeled compounds for biological applications. Ales has held various research positions, including Postdoctoral Research Associate at the University of Washington and IAEA grant-awarded postdoctoral researcher at the Technical University of Denmark. Educated at the University of Pardubice, Ales holds both a Master of Science and a Doctor of Philosophy in Organic Chemistry.
This person is not in any teams
IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
1 followers
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. Today, over 600 employees including 180 students in 45 research and service groups are involved in a broad spectra of disciplines, which results in more than 250 publications per year, including papers in the most cited prestigious journals such as Nature or Science. The Institute’s emphasis on interaction between chemistry and other sciences leads frequently to medicinal applications. An integral part of the mission of the Institute is, therefore, to transfer the scientific results into assets which help people to live better lives. Together with the research expertise, a system of technology transfer, IP management and commercialization have intensively been built-up. Through its subsidiary company IOCB TTO, the Institute helps scientists to transform ideas into patents and matches their research results with interests of commercial partners to bring novel ideas to human use or technology market.